XML 25 R14.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS' EQUITY
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS’ EQUITY
Stockholders’ Equity
The following tables present the changes in stockholders’ equity (in millions):
Three Months Ended March 31, 2025
Common StockAdditional Paid-In CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Intuitive Surgical, Inc. Stockholders’ EquityNoncontrolling Interest in Joint VentureTotal Stockholders’ Equity
SharesAmount
Beginning balance356.6 $0.4 $9,681.3 $6,803.3 $(51.3)$16,433.7 $95.9 $16,529.6 
Issuance of common stock through employee stock plans2.4 — 134.3 — — 134.3 — 134.3 
Shares withheld related to net share settlement of equity awards(0.6)— (7.8)(362.3)— (370.1)— (370.1)
Share-based compensation expense related to employee stock plans— — 185.9 — — 185.9 — 185.9 
Net income attributable to Intuitive Surgical, Inc.— — — 698.4 — 698.4 — 698.4 
Other comprehensive income— — — — 24.2 24.2 0.1 24.3 
Net income attributable to noncontrolling interest in joint venture— — — — — — 5.3 5.3 
Ending balance358.4 $0.4 $9,993.7 $7,139.4 $(27.1)$17,106.4 $101.3 $17,207.7 
Three Months Ended March 31, 2024
Common StockAdditional Paid-In CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Intuitive Surgical, Inc. Stockholders’ EquityNoncontrolling Interest in Joint VentureTotal Stockholders’ Equity
SharesAmount
Beginning balance
352.3 $0.4 $8,576.4 $4,743.0 $(12.2)$13,307.6 $89.7 $13,397.3 
Issuance of common stock through employee stock plans3.0 — 180.4 — — 180.4 — 180.4 
Shares withheld related to net share settlement of equity awards(0.6)— (6.6)(220.0)— (226.6)— (226.6)
Share-based compensation expense related to employee stock plans— — 152.8 — — 152.8 — 152.8 
Net income attributable to Intuitive Surgical, Inc.— — — 544.9 — 544.9 — 544.9 
Other comprehensive income (loss)— — — — 3.5 3.5 (0.4)3.1 
Cash dividends declared and payable by joint venture
— — — — — — (8.0)(8.0)
Net income attributable to noncontrolling interest in joint venture— — — — — — 2.5 2.5 
Ending balance
354.7 $0.4 $8,903.0 $5,067.9 $(8.7)$13,962.6 $83.8 $14,046.4 
Stock Repurchase Program
The Company’s Board of Directors (the “Board”) has authorized an aggregate of $10.0 billion of funding for the Company’s common stock repurchase program (the “Repurchase Program”) since its establishment in March 2009. The most recent authorization occurred in July 2022, when the Board increased the authorized amount available under the Repurchase Program to $3.5 billion, including amounts remaining under previous authorization. As of March 31, 2025, the remaining amount of share repurchases authorized by the Board under the Repurchase Program was approximately $1.1 billion.
The Company did not make any stock repurchases during the three months ended March 31, 2025, and 2024.
Accumulated Other Comprehensive Loss, Net of Tax, Attributable to Intuitive Surgical, Inc.
The components of accumulated other comprehensive loss, net of tax, attributable to Intuitive Surgical, Inc. are as follows (in millions):
Three Months Ended March 31, 2025
 Gains on Hedge InstrumentsUnrealized Gains (Losses) on Available-for-Sale SecuritiesForeign Currency Translation LossesEmployee Benefit PlansTotal
Beginning balance$11.0 $(14.6)$(33.1)$(14.6)$(51.3)
Other comprehensive income (loss) before reclassifications(16.0)29.1 5.4 — 18.5 
Amounts reclassified from accumulated other comprehensive income5.6 — — 0.1 5.7 
Net current-period other comprehensive income (loss)(10.4)29.1 5.4 0.1 24.2 
Ending balance$0.6 $14.5 $(27.7)$(14.5)$(27.1)
 Three Months Ended March 31, 2024
 Gains (Losses) on Hedge InstrumentsUnrealized Losses on Available-for-Sale SecuritiesForeign Currency Translation GainsEmployee Benefit PlansTotal
Beginning balance$(2.5)$(29.7)$19.4 $0.6 $(12.2)
Other comprehensive income (loss) before reclassifications4.1 (4.3)2.2 — 2.0 
Amounts reclassified from accumulated other comprehensive income (loss)1.5 0.1 — (0.1)1.5 
Net current-period other comprehensive income (loss)5.6 (4.2)2.2 (0.1)3.5 
Ending balance$3.1 $(33.9)$21.6 $0.5 $(8.7)
The tax impacts for amounts recognized in other comprehensive income before reclassifications and reclassified from accumulated other comprehensive loss relating to hedge instruments, available-for-sale securities, foreign currency translation gains (losses), and employee benefit plans for the three months ended March 31, 2025, and 2024, were not material to the Company’s Financial Statements.